ISSCR And Corning | ISSCR 2017 | Booth 607

Don’t let 2D cell culture hold back your research. Increase the predictive power of your assays with 3D cell culture tools from Corning. Visit us at ISSCR 2017, exhibit 607, to learn how Corning is easing the transition from 2D to 3D with tools, protocols, applications, and scientific support. Find out how you can conduct more biologically relevant research and better predict how your next discovery will behave in the real world.

Learn more about our featured solutions for stem cell research and register for our special innovation showcase, “Advances in Patient-derived Disease Modeling: from Standardized Reprogramming of iPS Cells to Generation of Human Kidney Organoids”.

Dr. Freedman will discuss the generation of human kidney organoids from pluripotent stem cells, and how this new technology is currently being applied to model disease, toxicity, and regeneration.

Dr. Freedman has studied vertebrate stem cells for two decades at four of the world’s premier universities. He performed his doctoral studies at the University of California at Berkeley and postdoctoral studies at Harvard Medical School. Hallmarks of his work include quantitative functional analysis of genetic mutants and reconstitution of complex phenomena in defined component systems. His lab is located in Seattle, Washington.

Dr. Anna Falk will discuss standardization of reprogramming and iPS cell cultures in defined and xeno-free conditions to minimize line variation for accurate and faithful in vitro disease modeling of human brain diseases.

Dr. Falk has almost 20 years’ experience in stem cell research. She holds a Ph.D. from Karolinska Institutet and was a post-doc at the Stem Cell Institute at the University of Cambridge, UK from 2007-2010. In 2012, Dr. Falk started her own research group, and is serving as Principal Investigator, where she is leading a research team in using iPS cells and neural differentiation to create in vitro models for human brain development in healthy and diseased samples. In addition, Dr. Falk established and serves as the director of the human iPS Core at Karolinska Institutet.

Dr. Keith Olson is the Director of Business Operations for Corning Life Sciences. Prior to joining Corning, Dr. Olson held positions in research and development, commercial operations, sales, business development, and senior management for several companies in the life sciences industry.

Dr. Olson holds a Bachelor of Science degree in Cell Biology from Carnegie Mellon University, a Master’s degree in Molecular Biology from the University of Rochester, and a Ph.D. in Cell and Molecular Biology from the University of Rochester.

Learn how NutriStem® hPSC XF medium, a defined, serum-free and xeno-free medium, was used to support the long-term culture of hiPSCs on Corning Matrigel® hESC-qualified matrix.

Watch our recent webinar to learn more about new methods for 3D cell culturing and how to apply them to high throughput screening assays. You'll also learn more about organoid assays being used in cancer research.

The use of extracellular matrix (ECM) proteins (natural, synthetic, or mimetic) as coatings on the cultureware allows the development of cell type specific model systems which more closely mimic in vivo conditions. Use the Corning selection guide to help you choose the best surface for your application and cell type.

One of our Corning media experts will walk you through the role that Cell culture media plays in successful and reproducible research. He’ll break down the classical mammalian cell culture media formulations and walk through the various mediums designed for different specific cell types and culturing conditions.